{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:28:34Z","timestamp":1790634514841,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T00:00:00Z","timestamp":1495756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.clbc.2017.05.008","type":"journal-article","created":{"date-parts":[[2017,5,20]],"date-time":"2017-05-20T04:01:38Z","timestamp":1495252898000},"page":"611-617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1009-5309","authenticated-orcid":false,"given":"Nicoletta","family":"Biglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Elisabetta","family":"Bounous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"D'Alonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ottino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Tuninetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Robba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2017.05.008_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/GME.0b013e31826560da","article-title":"Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer","volume":"20","author":"Baumgart","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2017.05.008_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-006-9260-6","article-title":"Quality of life of postmenopausal women in the ATAC (\u2018Arimidex\u2019, Tamoxifen Alone or in Combination) trial after completion of 5 years' adjuvant treatment for early stage breast cancer","volume":"100","author":"Cella","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2017.05.008_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1634\/theoncologist.11-2-96","article-title":"The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors","volume":"11","author":"Knobf","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.clbc.2017.05.008_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0378-5122(03)00087-2","article-title":"Menopause after breast cancer: a survey on breast cancers survivors","volume":"45","author":"Biglia","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.clbc.2017.05.008_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2012.09.013","article-title":"Extended adjuvant endocrine therapy in hormone dependent breast cancer: the paradigm of the NCIC-CTG MA.17\/BIG 1-97 trial","volume":"86","author":"Higgins","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clbc.2017.05.008_bib6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2017.05.008_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/13697137.2011.647840","article-title":"Vaginal Health: Insights, Views & Attitudes (VIVA) results from an international survey","volume":"15","author":"Nappi","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2017.05.008_bib8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/13697137.2014.946279","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society","volume":"17","author":"Portman","year":"2014","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2017.05.008_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/13697137.2013.795683","article-title":"Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health","volume":"16","year":"2013","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2017.05.008_bib10","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/GME.0b013e3182a122c2","article-title":"Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society","volume":"20","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2017.05.008_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","article-title":"The 2012 Hormone Therapy Position Statement of The North American Menopause Society Menopause","volume":"19","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2017.05.008_bib12","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1097\/AOG.0000000000001351","article-title":"ACOG Committee Opinion No. 659: The use of vaginal estrogen in women with a history of estrogen-dependent breast cancer","volume":"127","author":"Farrell","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clbc.2017.05.008_bib13","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","article-title":"Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on\u00a0the Primary Therapy of Early Breast Cancer 2015","volume":"26","author":"Coates","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2017.05.008_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clbc.2015.06.005","article-title":"Genitourinary syndrome of menopause in breast cancer survivors: are we facing new and safe hopes?","volume":"15","author":"Biglia","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2017.05.008_bib15","first-page":"1891","article-title":"Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight","volume":"7","author":"Biglia","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.clbc.2017.05.008_bib16","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1200\/JCO.2012.41.7915","article-title":"Sexuality in adult cancer survivors: challenges and intervention","volume":"30","author":"Bober","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2017.05.008_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1200\/JCO.2007.14.1655","article-title":"Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility","volume":"26","author":"Schover","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2017.05.008_bib18","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1200\/JCO.2015.64.8675","article-title":"Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen alone in premenopausal women with early breast cancer: patient-reported outcomes in the Suppression of Ovarian Function Trial","volume":"34","author":"Karin","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2017.05.008_bib19","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/annonc\/mdn353","article-title":"Practical guidelines for assessing and managing menopausal symptoms after breast cancer","volume":"19","author":"Hickey","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2017.05.008_bib20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1412379","article-title":"Adjuvant ovarian suppression in premenopausal breast cancer","volume":"372","author":"Francis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2017.05.008_bib21","first-page":"1790","article-title":"Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (Real Women's Views of Treatment Options for Menopausal Vaginal Changes) survey","volume":"10","author":"Kingsberg","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.clbc.2017.05.008_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"For the HABITS steering and data monitoring committees. HABITS (hormonal replacement therapy after breast cancer \u2013 is it safe?), a randomised comparison: trial stopped","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2017.05.008_bib23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":"Increased risk of recurrence after hormone replacement therapy in breast cancer survivors","volume":"100","author":"Holmberg","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2017.05.008_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/dji071","article-title":"Menopausal hormone replacement therapy after breast cancer: the Stockholm randomised trial","volume":"97","author":"Von Schoultz","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2017.05.008_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1470-2045(08)70341-3","article-title":"Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial","volume":"10","author":"Kenemans","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2017.05.008_bib26","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/jnci\/93.10.754","article-title":"Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality","volume":"93","author":"O'Meara","year":"2001","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2017.05.008_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/cmt.6.1.45.52","article-title":"A\u00a0cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer","volume":"6","author":"Dew","year":"2003","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2017.05.008_bib28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors","volume":"17","author":"Kendall","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2017.05.008_bib29","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/09513591003632258","article-title":"Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study","volume":"26","author":"Biglia","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.clbc.2017.05.008_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JOP.2011.000352","article-title":"Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator","volume":"8","author":"Wills","year":"2012","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.clbc.2017.05.008_bib31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10549-014-2930-x","article-title":"Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(\u00ae)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study","volume":"145","author":"Donders","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2017.05.008_bib32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/13697137.2010.529967","article-title":"Vaginal estriol to overcome side effects of aromatase inhibitors in breast cancer patients","volume":"14","author":"Pfeiler","year":"2011","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2017.05.008_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/09513590.2012.705389","article-title":"Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy","volume":"29","author":"Mariani","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.clbc.2017.05.008_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00042192-200205000-00006","article-title":"Treatment of urogenital atrophy with low-dose estradiol: preliminary results","volume":"9","author":"Santen","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2017.05.008_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.AOG.0000296714.12226.0f","article-title":"Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis. A randomised controlled trial","volume":"111","author":"Bachmann","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clbc.2017.05.008_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/13697137.2010.483297","article-title":"Minimized estradiol absorption with ultra-low dose 10 mcg 17 b-estradiol vaginal tablets","volume":"13","author":"Eugster-Mausmann","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2017.05.008_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/13697137.2011.583733","volume":"14","author":"Nieto","year":"2011","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2017.05.008_bib38","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/gme.0b013e3182518e9a","article-title":"The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study","volume":"19","author":"Cano","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2017.05.008_bib39","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/AOG.0b013e3181f386bb","article-title":"Endometrial safety of ultra-low dose estradiol vaginal tablets","volume":"116","author":"Simon","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clbc.2017.05.008_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-0-387-78818-0_2","article-title":"Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells","volume":"630","author":"Santen","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.clbc.2017.05.008_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13697137.2014.991301","article-title":"Vaginal estriol \u2013 lactobacilli combination and quality of life in endocrine-treated breast cancer","volume":"18","author":"Buchholz","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2017.05.008_bib42","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/GME.0000000000000401","article-title":"Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex\u00a0vivo study","volume":"22","author":"Salvatore","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2017.05.008_bib43","doi-asserted-by":"crossref","first-page":"49310","DOI":"10.1074\/jbc.M108896200","article-title":"The molecular interactions of heat shock protein 47 (Hsp47) and their implications for collagen biosynthesis","volume":"276","author":"Dafforn","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clbc.2017.05.008_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00128071-200304010-00001","article-title":"Can thermal lasers promote skin wound healing?","volume":"4","author":"Capon","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clbc.2017.05.008_bib45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/13697137.2014.899347","article-title":"A\u00a012-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study","volume":"17","author":"Salvatore","year":"2014","journal-title":"Climateric"},{"key":"10.1016\/j.clbc.2017.05.008_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/13697137.2014.975197","article-title":"Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy","volume":"18","author":"Salvatore","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2017.05.008_bib47","first-page":"1","article-title":"Fractional CO2 laser therapy: a new challenge for vulvo-vaginal atrophy in post menopausal women","author":"Siliquini","year":"2017","journal-title":"Climacteric"},{"key":"10.1016\/j.clbc.2017.05.008_bib48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3109\/13697137.2015.1045485","article-title":"Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause","volume":"18","author":"Gambacciani","year":"2015","journal-title":"Climacteric"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820917300952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820917300952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:16:01Z","timestamp":1761513361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820917300952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1526820917300952"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2017.05.008","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2017.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}